Capricor Therapeutics (CAPR) EPS (Basic) (2010 - 2026)
Capricor Therapeutics' (CAPR) quarterly EPS (Basic) came in at -$0.59 in Q1 2026, down 10.57% year-on-year from -$0.66 in Q1 2025, and up 14.34% quarter-over-quarter from -$0.69 in Q4 2025.
Capricor Therapeutics (CAPR) EPS (Basic) (2010 - 2026) Analysis & Trends
Capricor Therapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.59 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 10.57% year-over-year to -$0.59 in Q1 2026; TTM through Mar 2026 was -$3.74, a 8.1% increase from a year earlier, with the FY2025 full-year figure at -$2.26, down 96.69% from the prior year.
- EPS (Basic) grew to -$0.59 in Q1 2026 per CAPR's latest filing, from -$0.69 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.05 in Q4 2023 and bottomed at -$3.96 in Q3 2024.
- The 5-year median for EPS (Basic) is -$0.59 (2026), against an average of -$0.88.
- Across the five-year window, EPS (Basic) surged 83.06% in 2023 and slumped 862.52% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$0.3 in 2022, then jumped by 83.06% to -$0.05 in 2023, then plunged by 303.46% to -$0.21 in 2024, then slumped by 235.78% to -$0.69 in 2025, then climbed by 14.34% to -$0.59 in 2026.
- Per Business Quant, the three latest CAPR EPS (Basic) figures stand at -$0.59 (Q1 2026), -$0.69 (Q4 2025), and -$1.32 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Capricor Therapeutics | 1.12 Bn | 1.12 Bn | - | -0.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.59 |
| Dec 31, 2025 | -0.69 |
| Sep 30, 2025 | -1.32 |
| Jun 30, 2025 | -1.94 |
| Mar 31, 2025 | -0.53 |
| Dec 31, 2024 | -0.21 |
| Sep 30, 2024 | -3.96 |
| Jun 30, 2024 | -0.73 |
| Mar 31, 2024 | -1.31 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | -0.41 |
| Jun 30, 2023 | -0.77 |
| Mar 31, 2023 | -0.33 |
| Dec 31, 2022 | -0.30 |
| Sep 30, 2022 | -0.99 |
| Jun 30, 2022 | -0.48 |
| Mar 31, 2022 | -0.33 |
| Dec 31, 2021 | -0.27 |
| Sep 30, 2021 | -0.43 |
| Jun 30, 2021 | -0.22 |